Terms ending in 2029
Every in-force patent on Athenex, Inc.'s record whose computed term ends in 2029, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 7,939,529 | Process for the Preparation of Compositions for Modulating a Kinase Cascade and Methods of Use Thereof In force · High confidence | Atnx SPV, LLC | In force | High confidence | |
| US 7,851,470 | Composition and Methods for Modulating a Kinase Cascade In force · High confidence | Atnx SPV, LLC | In force | High confidence | |
| US 8,124,605 | Compositions and Methods for Modulating a Kinase Cascade In force · High confidence | Athenex, Inc. | In force | High confidence |
3 of 3 patents shown. Soonest term end first, then patent number.
1 of these is in force and held by Athenex, Inc..
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.